Altrafin AG’s AGNC Investment AGNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,000
Closed -$944K 60
2023
Q3
$944K Hold
100,000
0.41% 46
2023
Q2
$1.01M Hold
100,000
0.45% 46
2023
Q1
$1.01M Hold
100,000
0.5% 45
2022
Q4
$1.03M Hold
100,000
0.61% 41
2022
Q3
$842K Hold
100,000
0.5% 44
2022
Q2
$1.11M Buy
100,000
+32,500
+48% +$385K 0.6% 44
2022
Q1
$884K Hold
67,500
0.35% 59
2021
Q4
$1.02M Buy
+67,500
New +$1.07M 0.37% 59

Other funds holding AGNC

Altrafin AG's AGNC Position: Q4 2023 in Review

Altrafin AG sold out of AGNC Investment (AGNC) in Q4 2023, closing a stake of 100,000 shares — an estimated $944K sold.

Altrafin AG first reported a position in AGNC in Q4 2021 and held it in 8 quarters. The position peaked at $1.11M in Q2 2022. 469 funds tracked by Wall St. Rank hold AGNC as of Q4 2023.

  • Altrafin AG reported no remaining AGNC Investment position as of Q4 2023 after selling out during the quarter.
  • Altrafin AG sold 100,000 AGNC Investment shares in Q4 2023, an estimated $944K.
  • Altrafin AG first reported a position in AGNC Investment in Q4 2021 and held it in 8 quarters.
  • Altrafin AG's AGNC Investment position peaked at $1.11M in Q2 2022.
  • 469 funds tracked by Wall St. Rank held AGNC Investment as of Q4 2023.

Based on Altrafin AG's 13F filing for Q4 2023, filed 17 Feb 2026.